Cost sharing, family health care burden, and the use of specialty drugs for rheumatoid arthritis
about
Sociodemographic Determinants of Out-of-Pocket Expenditures for Patients Using Prescription Drugs for Rheumatoid Arthritis.Biologic Disease-Modifying Antirheumatic Drugs in a National, Privately Insured Population: Utilization, Expenditures, and Price TrendsAccess to oral osteoporosis drugs among female Medicare Part D beneficiaries.Specialty drug spending trends among Medicare and Medicare Advantage enrollees, 2007-11.Coverage for high-cost specialty drugs for rheumatoid arthritis in Medicare Part D.Time trends in medication use and expenditures in older patients with rheumatoid arthritisThe financial burden of out-of-pocket expenses in the United States and Canada: How different is the United States?Association of Medicare Part D medication out-of-pocket costs with utilization of statin medicationsBiologic therapy adherence, discontinuation, switching, and restarting among patients with psoriasis in the US Medicare population.Out-of-pocket medication costs and use of medications and health care services among children with asthma.Cost-related medication nonadherence in older patients with rheumatoid arthritis.Racial and ethnic disparities in rheumatoid arthritis.Impact of Cost-Sharing Increases on Continuity of Specialty Drug Use: A Quasi-Experimental Study.Disparities in care by insurance status for individuals with rheumatoid arthritis: analysis of the medical expenditure panel survey, 2006-2009.High Out-of-Pocket Medical Spending among the Poor and Elderly in Nine Developed Countries.
P2860
Q33572753-74571E0A-3198-4886-9282-9878A3497982Q33572758-C8F401EF-B9C3-4413-BD81-E3C8FB4C4157Q33841382-4C318F3C-FF20-4B35-917A-6E652A2B79B7Q34600764-4378FC10-6C1E-4895-A19A-C571D62602B9Q35731438-CEB07559-C749-4544-8437-0D8F6E594BC2Q36204927-B3EAFBAE-E083-4D43-831D-B691E224FD07Q36651089-E5B12AE9-3623-4DB9-9713-47268E0004BBQ37050954-7237FFEC-68A0-4919-8367-A926CF6215A4Q37095210-1933A07C-2BF7-4536-8BCF-E2275C636CDDQ37125842-270022A3-2D1C-45C5-8C46-98FE99748E64Q37274261-F0FB8613-3040-4F38-93FD-A0D91C393019Q38024756-A6B81472-4E4D-4077-8C4D-02FF135AE9B2Q38665413-C819E4CB-7658-4A3F-93CD-091C14AA00DDQ39463616-0FB66B6C-080C-4DFE-8DDA-D654B1450472Q40072944-B51BACFA-5A9A-4C05-97FD-6C4B50982EC5
P2860
Cost sharing, family health care burden, and the use of specialty drugs for rheumatoid arthritis
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Cost sharing, family health ca ...... drugs for rheumatoid arthritis
@ast
Cost sharing, family health ca ...... drugs for rheumatoid arthritis
@en
Cost sharing, family health ca ...... drugs for rheumatoid arthritis
@nl
type
label
Cost sharing, family health ca ...... drugs for rheumatoid arthritis
@ast
Cost sharing, family health ca ...... drugs for rheumatoid arthritis
@en
Cost sharing, family health ca ...... drugs for rheumatoid arthritis
@nl
prefLabel
Cost sharing, family health ca ...... drugs for rheumatoid arthritis
@ast
Cost sharing, family health ca ...... drugs for rheumatoid arthritis
@en
Cost sharing, family health ca ...... drugs for rheumatoid arthritis
@nl
P2093
P2860
P1476
Cost sharing, family health ca ...... drugs for rheumatoid arthritis
@en
P2093
Dana P Goldman
Geoffrey F Joyce
Marianne Laouri
Pinar Karaca-Mandic
P2860
P304
P356
10.1111/J.1475-6773.2010.01117.X
P433
P577
2010-10-01T00:00:00Z